Page 715 - Read Online
P. 715

Page 10 of 15                                             Wang et al. Hepatoma Res 2020;6:61  I  http://dx.doi.org/10.20517/2394-5079.2020.55

               curve (AUC) value than AFP alone. This study demonstrated the clinical significance of using CTC panel
                                                          [63]
               in diagnosis and real-time risk evaluation for HCC .

               Increasing efforts have been made to investigate the correlation between different molecular phenotypes
               of CTCs and corresponding clinical outcomes. The stem-like phenotype of CTC has been explored as a
                                                                                               -
               strong predictor of the clinical outcome of patients with HCC. For instance, circulating CD45  intercellular
                                                +
               cell adhesion molecule-1 (+) (ICAM-1 ) cells were regarded as HCC CTCs with stem cell-like properties.
                                                                       +
               Liu et al.  showed that patients with a higher burden of ICAM-1  CTCs had significantly shorter disease-
                       [46]
                                                                                                  +
                                                                                                         +
                                                                                            −
                                          [86]
               free survival and OS. Fan et al.  also reported that circulating cancer stem cells (CD45  CD90  CD44 )
               predicted post-hepatectomy HCC recurrence with high accuracy. Moreover, EMT subtypes of CTCs have
               been studied for the correlation to clinicopathological features and prognosis of HCC patients. It is reported
               that a presence or dominance of mesenchymal-like CTCs represented worse clinical outcomes for HCC
                                                                                                        TM
               patients due to earlier tumor relapse and metastasis [73,87] . The majority of these studies used the CanPatrol
               platform for CTC analysis [73,88-94] . In a cohort of 113 HCC patients (65% BCLC 0/A) and 57 non-malignant
               liver diseases patients, the system presented a higher diagnostic value (AUC = 0.774, 95%CI: 0.704-0.834)
               of HCC than AFP [0.669 (AUC = 0.669, 95%CI: 0.587-0.750)]. A further combination of CTCs and AFP
                                                                                 [92]
               showed the highest diagnostic capability (AUC = 0.821, 95%CI: 0.756-0.886) . The proportion of mixed
               EMT status CTCs or mesenchymal CTCs was associated with advanced BCLC stages, higher metastatic
                                                                 [90]
               tendency, and elevated serum levels of AFP [88,89] . Yin et al.  reported that twist expression in CTCs could
                                                                                          [93]
               serve as a biomarker for evaluating HCC metastasis and prognosis. Similarly, Wang et al.  studied 62 HCC
               patients undergoing surgical resection and found that mesenchymal CTC positivity was an independent
               risk factor for early recurrence. A similar study using CanPatrol  platform also found that CTCs
                                                                           TM
               undergoing EMT were significantly associated with early recurrence, multi-intrahepatic recurrence, and
                            [94]
               lung metastasis . However, a recent study reported that CTCs undergoing EMT were poorly correlated
                                                                                 [95]
               with clinical stages or predictive of recurrence of HCC using the platform . Another study using this
               platform also failed to uncover significant associations between change in total CTCs or CTC subtypes and
                                                                                            [96]
               HCC recurrence in a cohort consisting of 47 patients who underwent liver transplantation . Nevertheless,
                        [97]
               Xue et al.  utilized an iFISH® platform to detect CTCs in patients undergoing liver transplantation
               and found that patients with preoperative iFISH-CTCs ≥ 5 in 7.5 mL of blood had significantly shorter
               recurrence-free survival than those with lower CTCs. Further large, multicenter studies are still needed to
               confirm the association between different molecular phenotypes of CTCs and HCC prognosis.


               TUMOR MONITORING AND GUIDING PERSONALIZED THERAPEUTIC INTERVENTION IN HCC
               Surgical resection remains the most effective therapy for HCC. CTCs could serve as a complementary tool
                                                                                        [98]
               to assess the efficacy of surgical resection and monitor tumor progression [8,14] . Qi et al.  recently compared
               the outcomes of patients undergoing anatomical or non-anatomical resection according to the number
               and EMT phenotype of CTCs. They suggested that anatomic resection may improve the survival of HCC
               patients, for those with low CTC count, negative epithelial/mesenchymal hybrid CTCs, and mesenchymal
               CTCs. Thus, CTC analysis before surgery can be used to better guide the resection method for HCC.
                                                                                                        [99]
               Meanwhile, the decrease of CTC count after surgical treatment often reflects therapeutic efficacy. Fan et al.
               investigated the effect of liver tumor resection on CTC dynamics using in vivo flow cytometry (IVFC) in
               a green fluorescent protein-transfected HCC orthotopic metastatic mouse model. Their preliminary study
               found that the number of CTCs and early metastases rates decreased significantly after the resection of
               the primary tumor. Several clinical studies obtained similar results that CTC load decreased significantly
               after tumor resection, while increased CTC numbers after surgery were associated with a worse prognosis
               in patients with HCC [17,63,71,79,100] . Besides, Jin et al. [101]  explored the clinical value of serial postsurgical
               observation (at 0, 3, 6, 9, and 12 months) of AFP mRNA level of CTCs in assessing the therapeutic
               effectiveness of hepatectomy.
   710   711   712   713   714   715   716   717   718   719   720